There’s still scope for a new generation of drugs to replace weight-loss market leaders like Novo Nordisk A/S’s Wegovy, ...
GlobalData on MSN10d
GLP-1 drugs reduce US grocery spending by 6%, study claimsUsers of GLP-1 drugs in the US cut their grocery spending by an average of 5.5% in the six months after taking the medication, a study shows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback